Next Article in Journal
Binding of GS-461203 and Its Halogen Derivatives to HCV Genotype 2a RNA Polymerase Drug Resistance Mutants
Next Article in Special Issue
Preclinical Safety Profile of an Oral Naringenin/Hesperidin Dosage Form by In Vivo Toxicological Tests
Previous Article in Journal / Special Issue
Repurposing of Four Drugs as Anti-SARS-CoV-2 Agents and Their Interactions with Protein Targets
 
 
Article

Article Versions Notes

Sci. Pharm. 2022, 90(2), 25; https://doi.org/10.3390/scipharm90020025
Action Date Notes Link
article xml file uploaded 19 April 2022 10:58 CEST Original file -
article xml uploaded. 19 April 2022 10:58 CEST Update https://www.mdpi.com/2218-0532/90/2/25/xml
article pdf uploaded. 19 April 2022 10:58 CEST Version of Record https://www.mdpi.com/2218-0532/90/2/25/pdf
article html file updated 19 April 2022 10:59 CEST Original file -
article html file updated 2 August 2022 19:36 CEST Update https://www.mdpi.com/2218-0532/90/2/25/html
Back to TopTop